Abbott Laboratories is an Illinois-incorporated diversified healthcare company engaged in the discovery, development, manufacture, and sale of products across four reportable segments: Established Pharmaceutical Products (branded generic pharmaceuticals sold in emerging markets outside the U.S.), Diagnostic Products (diagnostic systems and tests sold worldwide), Nutritional Products, and Medical Devices. Established pharmaceutical therapeutic areas include gastroenterology, women's health, cardiovascular and metabolic, pain and central nervous system, respiratory and vaccines, and biologics/biosimilars.
The Established Pharmaceutical Products segment distributes primarily through wholesalers, distributors, government agencies, healthcare facilities, pharmacies, and independent retailers via Abbott-owned distribution centers or public warehouses depending on the market. In November 2025, Abbott announced a definitive agreement to acquire Exact Sciences Corporation to enter the cancer diagnostics market. Competition in the established pharmaceutical segment includes other healthcare and pharmaceutical companies as well as generic drug substitution and branded line extensions.
Non Us 38% · US 24% · All Other Countries 22% · DE 4% · …
geographic · FY2025 (ended Dec 2025) · share of tagged segment revenue (10-K XBRL, as filed)